Anhydro-and isomer-a-21978c cyclic peptides

Anhydro-and isomer-a-21978c cyclic peptides

Two new groups of A-21978C cyclic peptides, anhydro- and isomer-A21978C peptide derivatives, have antibacterial activity and are useful as intermediates. The two groups are prepared via transpeptidation of the parent cyclic peptides. Pharmaceutical formulations containing the new peptides as active...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Baker, Patrick J, Debono, Manuel, Farid, Khadiga Z, Molloy, R. Michael
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Baker, Patrick J
Debono, Manuel
Farid, Khadiga Z
Molloy, R. Michael
description Two new groups of A-21978C cyclic peptides, anhydro- and isomer-A21978C peptide derivatives, have antibacterial activity and are useful as intermediates. The two groups are prepared via transpeptidation of the parent cyclic peptides. Pharmaceutical formulations containing the new peptides as active ingredients and methods of treating infections caused by susceptible Gram-positive bacteria with the formulations are also provided.The invention also provides an antibacterial composition containing the new drug substance LY 146032 in substantially pure form.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_RE039071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RE039071</sourcerecordid><originalsourceid>FETCH-uspatents_grants_RE0390713</originalsourceid><addsrcrecordid>eNrjZNB2zMuoTCnK103MS1HILM7PTS3STdQ1MrQ0t0hWSK5MzslMVihILSjJTEkt5mFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJICrI1cDY0sDc0JgIJQDEOCl4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anhydro-and isomer-a-21978c cyclic peptides</title><source>USPTO Issued Patents</source><creator>Baker, Patrick J ; Debono, Manuel ; Farid, Khadiga Z ; Molloy, R. Michael</creator><creatorcontrib>Baker, Patrick J ; Debono, Manuel ; Farid, Khadiga Z ; Molloy, R. Michael ; Eli Lilly and Company</creatorcontrib><description>Two new groups of A-21978C cyclic peptides, anhydro- and isomer-A21978C peptide derivatives, have antibacterial activity and are useful as intermediates. The two groups are prepared via transpeptidation of the parent cyclic peptides. Pharmaceutical formulations containing the new peptides as active ingredients and methods of treating infections caused by susceptible Gram-positive bacteria with the formulations are also provided.The invention also provides an antibacterial composition containing the new drug substance LY 146032 in substantially pure form.</description><language>eng</language><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/RE39071$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/RE39071$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Baker, Patrick J</creatorcontrib><creatorcontrib>Debono, Manuel</creatorcontrib><creatorcontrib>Farid, Khadiga Z</creatorcontrib><creatorcontrib>Molloy, R. Michael</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><title>Anhydro-and isomer-a-21978c cyclic peptides</title><description>Two new groups of A-21978C cyclic peptides, anhydro- and isomer-A21978C peptide derivatives, have antibacterial activity and are useful as intermediates. The two groups are prepared via transpeptidation of the parent cyclic peptides. Pharmaceutical formulations containing the new peptides as active ingredients and methods of treating infections caused by susceptible Gram-positive bacteria with the formulations are also provided.The invention also provides an antibacterial composition containing the new drug substance LY 146032 in substantially pure form.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZNB2zMuoTCnK103MS1HILM7PTS3STdQ1MrQ0t0hWSK5MzslMVihILSjJTEkt5mFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJICrI1cDY0sDc0JgIJQDEOCl4</recordid><startdate>20060418</startdate><enddate>20060418</enddate><creator>Baker, Patrick J</creator><creator>Debono, Manuel</creator><creator>Farid, Khadiga Z</creator><creator>Molloy, R. Michael</creator><scope>EFH</scope></search><sort><creationdate>20060418</creationdate><title>Anhydro-and isomer-a-21978c cyclic peptides</title><author>Baker, Patrick J ; Debono, Manuel ; Farid, Khadiga Z ; Molloy, R. Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_RE0390713</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Baker, Patrick J</creatorcontrib><creatorcontrib>Debono, Manuel</creatorcontrib><creatorcontrib>Farid, Khadiga Z</creatorcontrib><creatorcontrib>Molloy, R. Michael</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Baker, Patrick J</au><au>Debono, Manuel</au><au>Farid, Khadiga Z</au><au>Molloy, R. Michael</au><aucorp>Eli Lilly and Company</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anhydro-and isomer-a-21978c cyclic peptides</title><date>2006-04-18</date><risdate>2006</risdate><abstract>Two new groups of A-21978C cyclic peptides, anhydro- and isomer-A21978C peptide derivatives, have antibacterial activity and are useful as intermediates. The two groups are prepared via transpeptidation of the parent cyclic peptides. Pharmaceutical formulations containing the new peptides as active ingredients and methods of treating infections caused by susceptible Gram-positive bacteria with the formulations are also provided.The invention also provides an antibacterial composition containing the new drug substance LY 146032 in substantially pure form.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_RE039071
source USPTO Issued Patents
title Anhydro-and isomer-a-21978c cyclic peptides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T10%3A51%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Baker,%20Patrick%20J&rft.aucorp=Eli%20Lilly%20and%20Company&rft.date=2006-04-18&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3ERE039071%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true